Jed Lewis is an innovative pharmacist that owns four pharmacies in Nebraska. But Lewis is doing something remarkable! By working with doctors and incorporating a line of "uniquely formulated" branded generics he has found a way to increase his gross profit by thousands of dollars. The company he works with is FH2 Pharma and in this episode he tells how he met the company's local sales rep and then started calling on doctors, with suggestions for using the new product line with specific patients, one's that would benefit most of the unique formulations. He shares that for nearly two years now he has found the program to be beneficial in two ways; one the products provide an unusually high reimbursement from all the major PBM's. But, because he visits the doctors and "details" the drug, he has learned how to get-in to see them and in doing so he is picking up a lot of new business as the doctors have come to know him and know he'll take good care of their patients. This is a must listen episode.

On this episode of the Pain Pod, we discuss the details of the PhARM OUD Guidelines with our special guest Dr. Tyler Varisco. We’re ready to dive into buprenorphine in community pharmacies, so buckle up and enjoy the ride! Come one, come all, to the Pain Pod!!! PhARM OUD Guidelines • https://forefdn.org/grantee-spotlight-engaging-community-pharmacists-in-improving-treatment-outcomes-for-patients-with-opioid-use-disorder/ Pain Guy • www.painguy.us • PhARM OUD Guideline Link on Pain Guy Website: https://painguy.us/resources

Dr. Tamara Ruggles (Host): www.linkedin.com/in/tamara-ruggles-491882251 Dr. Diana Isaacs (guest): linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426

In a world of analysis paralysis where medicine is more confusing than ever and the system seems rigged against health, today’s podcast guest is a breath of fresh air as she makes it simple to empower ourselves, and pave the way for the future: our children. Michelle Perro, MD, DHom is a seasoned clinician with over 40 years of experience in pediatrics and integrative medicine, dedicated to treating children and families. A Yale graduate, she trained at Mount Sinai Medical School, Bellevue Hospital and NYU, later serving as Director of a Pediatric Emergency Department in NYC and spending over a decade at UCSF Benioff Oakland Children’s Hospital. For the past 25 years, Dr. Perro has championed integrative approaches to health, focusing on the impact of Genetically Modified (GM) foods and pesticides on children’s well-being. She has lectured globally, and co-authored the acclaimed book What’s Making Our Children Sick? Dr. Perro is CEO and co-founder of www.gmoscience.org, promoting food as medicine and regenerative health education. She also hosts the podcast, The New MDS and offers parenting resources through her website. Her upcoming book, Making Our Children Well is set for release in 2026. Connect with Michelle via: Email: mdperro@earthlink.net Website: GMOScience FB: GMO Science X: @GMOScience YT: @gmoscience Spotify: The New MDs Linked In: Michelle Perro MD Audio Book: What's Making Our Children Sick?: How Industrial Food Is Causing an Epidemic of Chronic Illness, and What Parents (and Doctors) Can Do About It

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jeffrey S. Baird, Esq., Chairman of the Health Care Group at Brown & Fortunato, P.C. and Bradley W. Howard, shareholder and director at Brown & Fortunato, P.C. In today’s environment, it is challenging enough to profitably run a specialty pharmacy. The pharmacy needs to avoid the additional challenge of inquiries, audits and investigations by governmental agencies and PBMs. This podcast will discuss the proactive steps the specialty pharmacy can take to lower the risk of inquiries, audits and investigations. This podcast will also set out steps the pharmacy can take to resolve inquiries, audits and investigations before they spin out of control. The podcast will focus on the following: • Corporate Compliance Program – The specialty pharmacy needs to implement a robust compliance program that is specific to the pharmacy’s business model. Such a program will head off many problems before they arise…and a compliance program will resolve problems, once arisen, before they spin out of control. • PBMs – A PBM is in a stronger negotiating position than that of the specialty pharmacy. At the end of the day, the PBM “possesses the pharmacy’s money.” This podcast will discuss the steps the pharmacy should take to establish a “win-win” relationship with a PBM. Doing so will eliminate uncertainty and prevent many problems from arising. However, if the PBM ends up bringing an inquiry, audit or investigation against the pharmacy, the podcast will set out the steps the pharmacy should take to resolve the inquiry, audit or investigation without it devolving into an adversarial action. • Governmental Agencies – There are a number of federal and state governmental agencies that a specialty pharmacy may have to deal with. These include (i) the Department of Justice, (ii) the Office of Inspector General, (iii) the DEA, (iv) the FDA, (v) state Attorneys General, and (vi) State Boards of Pharmacy. This podcast will discuss the steps the pharmacy should take when it is investigated by a governmental agency. As with working with PBMs, the pharmacy should strive to resolve a government investigation before it spins out of control.

HealthPartners is joining forces with Perfecting Peds to bring life-changing medication management to Minnesota's sickest children. Many of these young patients, covered by Medicaid and the Health Exchange, manage complex medication regimens across multiple specialists. This partnership ensures they get the safest, most effective treatments-without the guesswork. By embedding specialized pediatric pharmacists directly into the care journey, HealthPartners and Perfecting Peds are bridging critical gaps between prescribing and outcomes—ensuring that every medication serves its intended purpose safely and effectively. This model of proactive, pharmacist-led intervention not only improves clinical outcomes, but also eases the emotional and logistical burdens on families. It empowers caregivers with clarity and support, transforming uncertainty into confidence. As other health systems look to elevate care for high-risk pediatric populations, this partnership serves as a blueprint for scalable, sustainable, and compassionate innovation in pharmacy-driven care. This is just the beginning. Co-Hosts: Jena Quinn, PharmD, BCPPS CEO and Founder Perfecting Peds Lyle Mioduszewski President Perfecting Peds Guests: Dr. Sarah Groen PharmD Clinical Pharmacist in Medication Therapy Management at HealthPartners